Abstract
Biologics started a new era in treatment of different aspects of rheumatic disases. Authors present the effects of anti-TNF therapy on ophtalmological complications in their patients with juvenile idiopathic artritis (JIA), juvenile dermatomiositis (JDM) and sarcoidosis.
Highlights
Biologics started a new era in treatment of different aspects of rheumatic disases
Retrospective chart rewiev of all rheumatic patients with ophtalmological complications treated with anti-TNF therapy at Division of Paediatric Rheumatology and Immunology, University Hospital Centre Zagreb, during 2009. – 2013. period
Among 54 children treated with anti-TNF therapy at our Division during 2009. – 2013. period, 10 were detected with ophtalmologycal complications (8 girls, 2 boys), 8 with juvenile idiopathic artritis (JIA), 1 with juvenile dermatomiositis (JDM) and 1 with sarcoidosis
Summary
Biologics started a new era in treatment of different aspects of rheumatic disases. Authors present the effects of anti-TNF therapy on ophtalmological complications in their patients with juvenile idiopathic artritis (JIA), juvenile dermatomiositis (JDM) and sarcoidosis. Effects of anti-TNF therapy on ophtalmological complications in children with rheumatic diseases From 21st European Pediatric Rheumatology (PReS) Congress Belgrade, Serbia. Introduction Biologics started a new era in treatment of different aspects of rheumatic disases.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have